Inventiva is a French biopharmaceutical company developing lanifibranor, an oral treatment for the liver disease MASH. It last closed at $3.14 on Nov 20, down 8.99% on the day.
AI Auto Pilots
Is IVA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IVA.
From IVA's SEC filings, latest 20-F for the period ending Jun 30, 2025 (filed Apr 8). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.
IVA · as of the Nov 20 close · updated each morning
Downtrend
The stock is 17% below its 20 day and 12% below its 50 day average. It is 49% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the swing low (Sep 24) at $3.10, and the nearest resistance the Pivot at $3.24.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 9.0%/day
Key levels
$7.2952 week high+132.2%
$4.67200 day average+48.7%
$4.04100 day average+28.7%
$3.72Swing high (Jun 23)+18.5%
$3.6720 day average+16.9%
$3.5250 day average+12.1%
$3.34Pivot R1+6.4%
$3.24Pivot+3.2%
$3.14Last close
$3.10Swing low (Sep 24)−1.3%
$3.03Pivot S1−3.5%
$2.8252 week low−10.2%
Indicators
RSI (14)
38.65
Weak, oversold below 30
Neutral
MACD
-0.07
Below its signal line
Bearish
Stochastic
19.0
Near the bottom of its range
Oversold
ADX (14)
23.1
Weak trend
Williams %R
-97.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-174.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−17.4%
Change over 10 sessions
Bearish
ATR (14)
$0.28
Typical daily range, 9.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Turning down
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityNormal, 18.7%/day
Key levels
$7.2952 week high+132.2%
$4.67200 day average+48.7%
$4.04100 day average+28.7%
$3.72Swing high (Jun 23)+18.5%
$3.6720 day average+16.9%
$3.5250 day average+12.1%
$3.34Pivot R1+6.4%
$3.24Pivot+3.2%
$3.14Last close
$3.10Swing low (Sep 24)−1.3%
$3.03Pivot S1−3.5%
$2.8252 week low−10.2%
Indicators
RSI (14)
38.47
Weak, oversold below 30
Neutral
MACD
-0.36
Below its signal line
Bearish
Stochastic
31.6
Middle of its range
Neutral
ADX (14)
15.6
No clear trend
Williams %R
-86.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-89.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−21.9%
Change over 10 sessions
Bearish
ATR (14)
$0.59
Typical daily range, 18.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IVA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IVA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IVA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IVAHow many large options trades hit IVA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IVA in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IVA is in one of them and how their past IVA trades turned out.
Inventiva is a biopharmaceutical company based in Daix, France. It focuses on developing treatments for MASH, a progressive chronic liver disease marked by fat buildup, inflammation and scarring in the liver. Its main candidate, lanifibranor, is an orally available small molecule that is being studied in patients with MASH. The company aims to offer the treatment to these patients if regulators approve it.